{"id":13773,"date":"2016-07-19T13:00:36","date_gmt":"2016-07-19T11:00:36","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13773"},"modified":"2021-07-19T13:03:39","modified_gmt":"2021-07-19T11:03:39","slug":"sabater-e-lopez-guillermo-a-rueda-a-salar-a-oyaguez-i-collar-jm","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/sabater-e-lopez-guillermo-a-rueda-a-salar-a-oyaguez-i-collar-jm\/","title":{"rendered":"Sabater E, L\u00f3pez-Guillermo A, Rueda A, Salar A, Oyag\u00fcez I, Collar JM"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13774 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/07\/applied_health_economics_and_health_policy-2.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Sabater E, L\u00f3pez-Guillermo A, Rueda A, Salar A, Oyag\u00fcez I, Collar JM<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Appl Health Econ Health Policy 2016;14(4):465-77<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/link.springer.com\/article\/10.1007\/s40258-016-0243-4\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sabater E, L\u00f3pez-Guillermo A, Rueda A, Salar A, Oyag\u00fcez I, Collar JM &nbsp; &nbsp; Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain Appl Health Econ Health Policy 2016;14(4):465-77 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,933,346],"tags":[],"class_list":["post-13773","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-hematologia-oncohematologia","category-applied-health-economics-and-health-policy","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13773"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13773"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13773\/revisions"}],"predecessor-version":[{"id":13775,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13773\/revisions\/13775"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}